BKK:BKGI Revenue

Bangkok Genomics Innovation PCL had revenue of 155.34M THB in the quarter ending June 30, 2026, with 122.56% growth. This brings the company's total for the last twelve months to 538.69M, up 62.35% year-over-year. In the year 2025, Bangkok Genomics Innovation PCL had annual revenue of 379.51M with 12.42% growth. That makes Bangkok Genomics Innovation PCL the 35,094th largest company in the world by revenue and 732nd in Thailand.

Revenue (ttm)

538.69M

Revenue Growth

+62.35%

P/S Ratio

2.56

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.38B

Revenue Chart

Chart

Revenue by Segment

Chart

Testing and Analysis Services 267.25M 69.8%
Sale of Laboratory Reagents and Related Products 102.71M 26.8%
Sale Advanced Therapy Medicinal Product 12.82M 3.3%

Fiscal year ended Dec 31, 2025 See the full BKK:BKGI breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	379.51M	41.92M	12.42%
Dec 31, 2024	337.59M	92.20M	37.57%
Dec 31, 2023	245.39M	-59.38M	-19.48%
Dec 31, 2022	304.77M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.